You, Dahea;
Lyn-Cook, Lascelles E;
Gatti, Daniel M;
Bell, Natalie;
Mayeux, Philip R;
James, Laura P;
Mattes, William B;
Larson, Gary J;
Harrill, Alison H
Nitrosative Stress and Lipid Homeostasis as a Mechanism for Zileuton Hepatotoxicity and Resistance in Genetically Sensitive Mice
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Nitrosative Stress and Lipid Homeostasis as a Mechanism for Zileuton Hepatotoxicity and Resistance in Genetically Sensitive Mice
Contributor:
You, Dahea;
Lyn-Cook, Lascelles E;
Gatti, Daniel M;
Bell, Natalie;
Mayeux, Philip R;
James, Laura P;
Mattes, William B;
Larson, Gary J;
Harrill, Alison H
Published:
Oxford University Press (OUP), 2020
Published in:
Toxicological Sciences, 175 (2020) 2, Seite 220-235
Language:
English
DOI:
10.1093/toxsci/kfaa037
ISSN:
1096-6080;
1096-0929
Origination:
Footnote:
Description:
AbstractZileuton is an orally active inhibitor of leukotriene synthesis for maintenance treatment of asthma, for which clinical usage has been associated with idiosyncratic liver injury. Mechanistic understanding of zileuton toxicity is hampered by the rarity of the cases and lack of an animal model. A promising model for mechanistic study of rare liver injury is the Diversity Outbred (J:DO) mouse population, with genetic variation similar to that found in humans. In this study, female DO mice were administered zileuton or vehicle daily for 7 days (i.g.). Serum liver enzymes were elevated in the zileuton group, with marked interindividual variability in response. Zileuton exposure-induced findings in susceptible DO mice included microvesicular fatty change, hepatocellular mitosis, and hepatocellular necrosis. Inducible nitric oxide synthase and nitrotyrosine abundance were increased in livers of animals with necrosis and those with fatty change, implicating nitrosative stress as a possible injury mechanism. Conversely, DO mice lacking adverse liver pathology following zileuton exposure experienced decreased hepatic concentrations of resistin and increased concentrations of insulin and leptin, providing potential clues into mechanisms of toxicity resistance. Transcriptome pathway analysis highlighted mitochondrial dysfunction and altered fatty acid oxidation as key molecular perturbations associated with zileuton exposure, and suggested that interindividual differences in cytochrome P450 metabolism, glutathione-mediated detoxification, and farnesoid X receptor signaling may contribute to zileuton-induced liver injury (ZILI). Taken together, DO mice provided a platform for investigating mechanisms of toxicity and resistance in context of ZILI which may lead to targeted therapeutic interventions.